MeSH tree: D12.776.260
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked. FIU researchers have now uncovered a previously unknown mechanism that helps explain how HIV causes ...
Apr 25, 2026
0
8
Cancer drugs are designed to shut tumors down. But sometimes, in the very act of attacking a tumor, treatment can also help a small fraction of cancer cells become harder to kill. A new study from researchers at the Institute ...
Apr 15, 2026
0
7
Researchers from the Icahn School of Medicine at Mount Sinai have discovered a molecular switch in neurons that limits the regrowth of damaged axonal fibers. The findings, published in the journal Nature, show that blocking ...
Apr 1, 2026
0
7
A fall on the head, a blow to the skull, or a road traffic accident—the causes of traumatic brain injury are diverse, but the severe forms have a common denominator: immune reactions and inflammatory processes are added on ...
Mar 25, 2026
0
5
For decades, scientists have recognized that human immunodeficiency virus (HIV) is a formidable viral pathogen. After years of probing work and extensive experimentation, a Yale research team has unlocked one of the reasons ...
Mar 13, 2026
0
13
Researchers have revealed how a common bacterium, Enterococcus faecalis (E. faecalis), releases lactic acid to acidify its surroundings and suppress the immune-cell signal needed to start a proper response to infection. By ...
Mar 12, 2026
0
9
Something happens when a rat starts running. Not just the obvious things, the faster heart, the warming muscles, the rhythmic percussion of paws against the wheel. Something quieter. Something that begins in the coiled darkness ...
Mar 10, 2026
0
46
Memorial Sloan Kettering Cancer Center investigators and collaborators have tested rezatapopt, an oral p53 reactivator designed for tumors with TP53 Y220C, and observed antitumor activity across multiple solid tumor types ...
Globally, millions of people are affected by Alzheimer's disease, with around 120,000 individuals in Norway alone. Witnessing a loved one gradually decline because of this devastating condition can be heart-wrenching. "Alzheimer's ...
Feb 19, 2026
0
9
A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor treatment, and blocking this early response may make this class of drugs work better. ...
Feb 12, 2026
0
19
